Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 1,259 | 42,132 | 744 | 0 | 0 |
| Gross Profit | 1,259 | 42,132 | 744 | N/A | N/A |
| Operating Expenses | 9,082 | 13,546 | 9,264 | 12,102 | 12,616 |
| Operating Income | -7,823 | 28,586 | -8,520 | -12,102 | -12,616 |
| Interest Expense | 602 | 608 | 599 | 370 | 55 |
| Other Income | 10 | -2,563 | 8,528 | -421 | -741 |
| Pre-tax Income | -8,415 | 25,415 | -591 | -12,893 | -13,412 |
| Net Income Continuous | -8,415 | 25,415 | -591 | -12,893 | -13,412 |
| Net Income | $-8,415 | $25,415 | $-591 | $-12,893 | $-13,412 |
| EPS Basic Total Ops | -1.40 | 4.83 | -0.10 | -2.40 | -2.60 |
| EPS Basic Continuous Ops | -1.41 | 4.83 | -0.10 | -2.44 | -2.55 |
| EPS Diluted Total Ops | -1.40 | 4.83 | -0.10 | -2.40 | -2.60 |
| EPS Diluted Continuous Ops | -1.41 | 4.83 | -0.10 | -2.44 | -2.55 |
| EBITDA(a) | $-6,477 | $29,981 | $-7,225 | $-10,934 | $-11,438 |